Literature DB >> 3508049

Creatine kinase brain isoenzyme in infantile osteopetrosis.

Y Hiroyama1, T Miike, S Sugino, K Taku.   

Abstract

A 14-month-old girl with infantile osteopetrosis had hematologic and neurologic complications with severe brain atrophy. Although serum contained high creatine kinase brain isoenzyme activity (CK-BB), CK-BB activity was not detected on repeated cerebrospinal fluid examinations. After frequent blood transfusions and steroid therapy, hematologic involvement improved gradually and disappeared finally at age 11 months; serum CK-BB tended to show a concomitant proportional increase in activity. A 111Indium chloride scan was performed at age 4 weeks when the patient had relatively low serum CK-BB activity. It indicated active extramedullary hematopoiesis in the liver and spleen. The second scan was performed at age 12 months when she had high serum CK-BB activity and indicated active medullary hematopoiesis in the cranium. The tests disclosed that the elevated serum CK-BB activity was the result of bone marrow serum leakage, and not leakage from brain tissue. This finding may be a good marker of medullary hematopoietic activity in patients with osteopetrosis. Meanwhile, biopsied sural nerve revealed storage of cellular debris, including myelin figures in the Schwann cells, which suggested increased degradation process in the cells or lysosomal enzyme deficiency.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3508049     DOI: 10.1016/0887-8994(87)90057-9

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

1.  Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II.

Authors:  J Gram; S Antonsen; M Hørder; J Bollerslev
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

2.  Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications.

Authors:  Mattia Capulli; Antonio Maurizi; Annabel Curle; Rajvi Patel; Argia Ucci; Juliana Alves Côrtes; Harriet Oxford; Shireen R Lamandé; John F Bateman; Nadia Rucci; Anna Teti
Journal:  Bone Res       Date:  2019-06-11       Impact factor: 13.567

Review 3.  The Role of the Lysosomal Cl-/H+ Antiporter ClC-7 in Osteopetrosis and Neurodegeneration.

Authors:  Giovanni Zifarelli
Journal:  Cells       Date:  2022-01-21       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.